Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $461.1300 (-1.8%) ($460.6600 - $472.3100) on Tue. Oct. 10, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.77% (three month average) | RSI | 66 | Latest Price | $461.1300(-1.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 3.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(50%) IVW(43%) XBI(43%) IWF(42%) | Factors Impacting REGN price | REGN will decline at least -0.885% in a week (0% probabilities). UUP(-9%) VIXM(-7%) TLT(-6%) TIP(-1%) SHY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.885% (StdDev 1.77%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
5 Day Moving Average | $464.02(-0.62%) | 10 Day Moving Average | $456.21(1.08%) | 20 Day Moving Average | $446.28(3.33%) | To recent high | -11.5% | To recent low | 6.9% | Market Cap | $48.893b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |